Mouse models expressing mutant IDH1 or IDH2 showed similar patterns to those found in AML patients such as increased early hematopoietic progenitors, splenomegaly, anemia, hypermethylated DNA, and histone signatures. This evidence concerns the gene IDH2 and acute myeloid leukemia.